Fujikura
5803
Nippon Telegraph & Telephone
9432
Remixpoint
3825
4
Rakuten Group
4755
5
Toyota Motor
7203
JP Stock MarketDetailed Quotes
2160 GNI Group
- 3355
- +10+0.30%
20min DelayNot Open Feb 14 15:30 JST
168.31BMarket Cap178.17P/E (Static)
3425High3340Low666.90KVolume3380Open3345Pre Close2.25BTurnover386552wk High1.41%Turnover Ratio50.17MShares153752wk Low18.83EPS TTM158.69BFloat Cap4070Historical High178.17P/E (Static)47.30MShs Float13Historical Low18.83EPS LYR2.54%Amplitude--Dividend TTM4.62P/B100Lot Size--Div YieldTTM
About GNI Group Company
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
Company Profile
Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees839
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Ying Luo, PhD
- Director, Representative Executive Officer, President and Chief Executive Officer
- --
- Toshiya Kitagawa
- Director, Executive Officer and Chief Financial Officer
- --
- Sekitani Kazuki
- Director, Executive Officer and Chief Operating Officer
- --
- Thomas Eastling
- Director
- --
- Ryosuke Matsui
- Director
- --
- Zhang Ping
- Independent Director
- --
- Kikuchi Kanako
- Independent Director
- --
- Hideaki Sashiwa
- Independent Director
- --